Biolife Solutions BLFS
NASDAQ BLFS
$34.73 -0.20 (-0.57%)
As of: Sep 10, 2026 · 3:09 PM EDT

Biolife Solutions (BLFS) Income from Continuing Operations (2010 - 2026)

Biolife Solutions' (BLFS) quarterly Income from Continuing Operations came in at $45.1 million in Q2 2026, up 394.39% year-over-year from $9.1 million in Q2 2025, and up 3828.92% quarter-over-quarter from $1.1 million in Q1 2026.

Analysis

Biolife Solutions (BLFS) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Biolife Solutions (BLFS) has reported Income from Continuing Operations for 17 consecutive years, with $45.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Income from Continuing Operations rose 394.39% year-over-year to $45.1 million in Q2 2026; TTM through Jun 2026 was $50.4 million, a 434.36% increase from a year earlier, with the FY2025 full-year figure at -$12.1 million, down 38.08% from the prior year.
  • Income from Continuing Operations was $45.1 million for Q2 2026 at Biolife Solutions, up from $1.1 million in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at $91.0 million in Q4 2022 and troughed at -$72.9 million in Q2 2022.
  • A 5-year average of $545055.6 and a median of -$1.8 million in 2024 frame the typical range for Income from Continuing Operations.
  • Across the five-year window, Income from Continuing Operations tumbled 13159.49% in 2022 and jumped 694.38% in 2025, its largest moves.
  • Over 5 years, Income from Continuing Operations stood at $91.0 million in 2022, then plunged by 80.35% to $17.9 million in 2023, then sank by 97.51% to $445000.0 in 2024, then jumped by 694.38% to $3.5 million in 2025, then jumped by 1175.93% to $45.1 million in 2026.
  • The last three Income from Continuing Operations figures came in at $45.1 million (Q2 2026), $1.1 million (Q1 2026), and $3.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Thermo Fisher Scientific 223.35 Bn 219.29 Bn 8.34 Bn 1.76 Bn
2 Danaher 141.93 Bn 137.59 Bn 3.61 Bn 870.00 Mn
3 Agilent Technologies 40.25 Bn 38.49 Bn 1.04 Bn 362.00 Mn
4 Illumina 30.62 Bn 29.46 Bn 770.00 Mn 207.00 Mn
5 Revvity 13.52 Bn 12.49 Bn 416.87 Mn 53.48 Mn
6 Bio-Techne 11.27 Bn 11.00 Bn 211.39 Mn 54.62 Mn
7 Bio-Rad Laboratories 9.91 Bn 8.30 Bn 345.80 Mn 371.40 Mn
8 Repligen 9.20 Bn 8.19 Bn 110.04 Mn 5.01 Mn
9 10x Genomics 8.70 Bn 8.15 Bn 112.50 Mn -17.93 Mn
10 Biolife Solutions 1.70 Bn 1.61 Bn 18.29 Mn 45.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 45.10 Mn
Mar 31, 2026 1.15 Mn
Dec 31, 2025 3.54 Mn
Sep 30, 2025 621,000.00
Jun 30, 2025 -15.32 Mn
Mar 31, 2025 271,000.00
Dec 31, 2024 445,000.00
Sep 30, 2024 -471,000.00
Jun 30, 2024 -5.56 Mn
Mar 31, 2024 -3.20 Mn
Dec 31, 2023 17.89 Mn
Sep 30, 2023 -15.80 Mn
Jun 30, 2023 -5.52 Mn
Mar 31, 2023 -13.71 Mn
Dec 31, 2022 91.00 Mn
Sep 30, 2022 -10.32 Mn
Jun 30, 2022 -72.88 Mn
Mar 31, 2022 -7.42 Mn
Dec 31, 2021 -15.75 Mn
Sep 30, 2021 79,000.00